Reply Receives Microsoft Advanced Specialization Status Across Six Categories in Five Months
Reply, with its award-winning companies Cluster Reply, Solidsoft Reply, Valorem Reply, WM Reply and Business Elements, announced today that it has received Microsoft Advanced Specialization status across six categories in five months.
Microsoft Advanced Specialization status denotes deep knowledge in a specific area, and between February and June, Reply – already a Microsoft Gold Partner in Europe, North and Latin America, and a Microsoft Azure Expert Managed Services Provider (MSP) – received specialist status in:
- Microsoft Windows Virtual Desktop
- Windows Server and SQL Server Migration to Microsoft Azure
- Kubernetes on Microsoft Azure
- Modernization of Web Applications to Microsoft Azure
- Calling for Microsoft Teams
- Analytics on Microsoft Azure
In addition to the 16 Microsoft Gold competencies held by Reply that show broad technical capability in a Microsoft product, Advanced Specialization status is reserved for partners meeting stringent criteria with regards customer success and staff skilling.
The first half performance builds upon a successful 2020, when Reply was awarded the Microsoft “Adoption and Change Management Advanced Specialization” in recognition of its deep knowledge, extensive experience, and proven success driving organizational change through Microsoft 365.
Filippo Rizzante, CTO Reply, said: "We are pleased of these recognitions which attest the technical skills and the expertise of our teams to successfully implement Microsoft services and solutions. Through our partnership with Microsoft we have achieved great results and we are proud of the success of our teams, confirmed by the seven Advanced Specializations achieved so far. We will continue to keep the pace over the coming months to get new specializations in order to help customers to become agile, resilient and innovative market leaders with the support of modern cloud technologies."
The Advanced Specializations at a glance:
- The “Microsoft Windows Virtual Desktop” Advanced Specialization validates Reply’s deep expertise in deploying and scaling virtualized desktops and applications on Azure using Windows Virtual Desktop;
- The “Windows Server and SQL Server Migration to Microsoft Azure” Advanced Specialization demonstrates Reply’s expertise in migrating and optimizing Windows Server and SQL Server-based workloads to Microsoft Azure;
- The “Kubernetes on Microsoft Azure” Advanced Specialization allows Reply to further differentiate itself by demonstrating the proven success in deploying and managing production workloads in the cloud using containers and managing hosted Kubernetes environments in Microsoft Azure;
- The “Modernization of Web Applications to Microsoft Azure” Advanced Specialization confirms Reply’s expertise and proven success in migrating and deploying production web application workloads, applying DevOps practices, and managing application services in Microsoft Azure;
- The “Calling for Microsoft Teams” Advanced Specialization demonstrates deep knowledge, extensive experience, and proven success in deploying and managing Microsoft 365 Phone System;
- The “Analytics on Microsoft Azure” Advanced Specialization validates Reply’s deep expertise in planning and deploying Azure cloud analytics services, enabling customers to use the full breadth of their data assets to help build transformative and secure analytical solutions at enterprise scale.
Reply
Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of AI, big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210930005034/en/
Contact information
Media
Reply
Fabio Zappelli
f.zappelli@reply.com
Tel. +390117711594
Aaron Miani
a.miani@reply.com
Tel. +44 (0)20 7730 6000
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab18.11.2025 09:23:00 EET | Press release
Celltrion, Inc. today announced that the European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab. Approved in 100 mg and 350 mg vials, the formulation is designed to streamline infusion preparation, reduce healthcare professionals’ workload, and support hospital operational efficiency.3 The Remsima™ IV liquid formulation is approved in the EU for all indications of IV infliximab, matching the approved uses of all existing IV infliximab powder formulations, including rheumatoid arthritis (RA), adult and pediatric Crohn’s disease (CD), ulcerative colitis (UC), pediatric UC, ankylosing spondylitis (AS), psoriatic arthritis (PsA), and psoriasis (PsO).1 The comparability between lyophilized powder formulation and the liquid formulation of IV infliximab has been established through comprehensive chemistry, manufacturing, and controls data.2 The stability of the liquid formulation of I
Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New "Ideal Japan” Program18.11.2025 09:00:00 EET | Press release
Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company aiming to cure cancer and infectious diseases, is pleased to announce today the launch of the new IDEAL Japan initiative. This program was initiated to provide financial support to Japanese academic researchers in order to facilitate the transformation of academic innovation into novel therapeutic approaches for combating cancer. IDEAL Japan follows the conclusion of the highly respected JCA (Japanese Cancer Association) Mauvernay Award in Japan, which honored Japanese scientists over the last 20 years, from 2004 through 2024. Debiopharm is now transitioning its historic award into the IDEAL Japan initiative aiming to accelerate preclinical scientific research that could give rise to new treatments for cancer patients. “Our vision is to collaborate to find a cure for cancer,”explained Thierry Mauvernay, President of Debiopharm. “We believe that our ongoing Swiss-Japanese connection needs to evolve and catalyze the trans
Avanzanite Bioscience Secures €32M Series A Investment from MVM Partners18.11.2025 08:00:00 EET | Press release
Avanzanite Bioscience B.V. (Avanzanite), a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced a €32 million Series A growth investment from MVM Partners (MVM), a leading global life-science private equity firm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117345890/en/ Adam Plich, Founder and CEO of Avanzanite. The announcement follows a record-breaking Q3 2025 for Avanzanite, with revenue tripling year-on-year and climbing over 20% quarter-on-quarter. This strategic funding will accelerate the expansion of Avanzanite’s pan-European infrastructure and propel both current and future rare disease product launches. The capital will also enable Avanzanite to form new strategic alliances and acquire assets to expand its portfolio. Avanzanite was built to solve Europe’s rare-disease medicines access gap. Under one pan-European operation, Avanzanite brings toget
Over 30 Million Users Benefit From Ant International’s Bettr Credit Tech Solutions18.11.2025 05:35:00 EET | Press release
Bettr, a leading provider of inclusive financial services and technology business under Ant International, today announced the launch of its proprietary tailored, one-stop credit tech solutions designed to help digital platforms build and scale their lending businesses to better serve micro, small and medium enterprises (MSMEs) in emerging markets. Bettr's credit tech solutions supported over 30 million customers to gain access to credit services through its partners by the end of October 2025, marking a threefold increase compared to the same period in 2024, with MSMEs among the key segments driving this growth. International Finance Corporation estimates a US$8 trillion financing gap for MSMEs in emerging markets and developing economies. With global platforms, from e-commerce to food delivery, entering emerging markets and local platforms in these markets continue to scale, many are looking to offer tailored credit services to better support MSMEs operating on their ecosystems. Doin
Ant International Deepens Participation in Project Ensemble as New Architecture Community Member18.11.2025 05:00:00 EET | Press release
Ant International today announced it has joined Project Ensemble’s Architecture Community to support the design and advancement of Hong Kong’s tokenisation ecosystem. As a Community member, it will be more involved in defining industry standards and supporting the development of Hong Kong’s tokenisation market, together with the Hong Kong Monetary Authority (HKMA) and leading peers. A fintech representative on the Community, Ant International will also contribute its technological and innovation capabilities in tokenisation to support broader industry adoption. This comes at a time when Project Ensemble reaches a new milestone with EnsembleTX, which will see it move from sandbox experiments to live market use within a pilot environment. Through EnsembleTX, Ant International will continue to broaden its partnerships with banks and other committee members, contributing to real-world use cases of tokenisation in real-time global treasury management. It has already supported a successful H
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom